2008 Annual Meeting | Management of Common Behavioral Disturbances in Dementia
| 06:00 PM - 06:20 PM |
Introduction
Kimford J. Meador, MD, FAAN |
|
| 06:00 PM - 09:00 PM |
Dinner
|
|
| 06:20 PM - 07:10 PM |
Imaging Correlates of Behavioral Disorders in Dementia
Liana Apostolova, MD, FAAN |
|
| 07:10 PM - 08:00 PM |
Pharmacologic Management of Behavioral Disorders in Dementia
David Geldmacher, MD |
|
| 08:00 PM - 08:50 PM |
Case Studies
Kimford J. Meador, MD, FAAN |
|
| 08:50 PM - 09:00 PM |
Discussion
|
| Kimford J. Meador, MD, FAAN | The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from Eisai. The institution of Dr. Meador has received research support from Medtronics. The institution of Dr. Meador has received research support from The Epilepsy Consortium. |
| David Geldmacher, MD | Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Geldmacher has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BrownGreer. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Penn Partners. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oligomerix. Dr. Geldmacher has stock in Doximity. The institution of Dr. Geldmacher has received research support from Biogen. The institution of Dr. Geldmacher has received research support from Eisai. The institution of Dr. Geldmacher has received research support from Janssen. The institution of Dr. Geldmacher has received research support from National Institutes of Health. The institution of Dr. Geldmacher has received research support from Vaccinex. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a CME presenter with Medscape. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a CME presenter with Med Learning Group. Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a CME presenter/committee member with HMP . Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a CME program development/presenter with CME Institute. |
| Liana Apostolova, MD, FAAN | Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. An immediate family member of Dr. Apostolova has stock in Cassava Neurosciences. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging. |